Articles

Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG)

Department of Internal Medicine III, Ulm University, Ulm, Germany;
Institute of Applied Biosciences, Centre for Research and Technology, Thessaloniki, Greece;
Department of Internal Medicine III, Ulm University, Ulm, Germany;
Dept I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, Cologne, Germany;
Dept I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, Cologne, Germany;
Department of Internal Medicine III, Ulm University, Ulm, Germany;
Department of Internal Medicine III, Ulm University, Ulm, Germany;
Department of Hematology, Oncology, Munchen Klinik Schwabing, Munich, Germany;
Dept I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, Cologne, Germany;
Dept I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, Cologne, Germany;
Dept I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, Cologne, Germany;
Dept I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, Cologne, Germany;
Department of Internal Medicine III, Ulm University, Ulm, Germany;
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden;
Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy
Institute of Applied Biosciences, Centre for Research and Technology, Thessaloniki, Greece;
Department of Internal Medicine III, Ulm University, Ulm, Germany;
Haematologica Early view Dec 26, 2019 https://doi.org/10.3324/haematol.2019.231027